captopril has been researched along with Colorectal Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christophi, C; Fifis, T; Gordon, CL; Kastrappis, G; Muralidharan, V; Perini, MV; Riddiough, GE; Tran, BM; Vincan, E; Walsh, KA | 1 |
| Christophi, C; Fifis, T; Kastrappis, G; Paolini, R; Perini, MV; Vallejo Ardila, DL; Walsh, KA | 1 |
| Diz-Muñoz, A; Freire Valls, A; Imle, A; Liang, J; Lu, J; Muley, T; Radhakrishnan, P; Ruiz de Almodovar, C; Salfenmoser, M; Schleussner, N; Schmidt, T; Schneider, M; Shen, Y; Wang, G; Wang, X; Wirsik, NM | 1 |
| Ager, EI; Christophi, C; Neo, J; Wen, SW | 1 |
| Ager, EI; Christophi, C; Costa, PL; Koh, SL; Malcontenti-Wilson, C; Muralidharan, V | 1 |
| Ager, EI; Angus, PW; Christophi, C; Herath, CB; Neo, JH; Zhu, J | 1 |
| Ager, EI; Chan, J; Chong, WW; Christophi, C; Neo, JH; Wen, SW | 1 |
| Alberti, A; Corrada, E; Ferrari, S; Mafrici, A; Marenna, B | 1 |
| Christophi, C; Malcontenti-Wilson, C; Muralidharan, V; Neo, JH | 1 |
| Curwen, JO; Kendrew, J; Musgrove, HL; Ogilvie, DJ; Richmond, GH; Wedge, SR | 1 |
10 other study(ies) available for captopril and Colorectal Neoplasms
| Article | Year |
|---|---|
Captopril, a Renin-Angiotensin System Inhibitor, Attenuates Tumour Progression in the Regenerating Liver Following Partial Hepatectomy.
Topics: Animals; Antihypertensive Agents; Captopril; Colorectal Neoplasms; Enzyme Inhibitors; Hepatectomy; Humans; Liver Neoplasms; Mice; Neoplasm Recurrence, Local; Programmed Cell Death 1 Receptor; Renin-Angiotensin System; Tumor Microenvironment | 2022 |
Immunomodulatory effects of renin-angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carcinoma; Cell Line, Tumor; Colorectal Neoplasms; Disease Models, Animal; Humans; Liver Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Mice; Renin-Angiotensin System; T-Lymphocytes | 2020 |
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer.
Topics: Angiogenesis Inhibitors; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bevacizumab; Cancer-Associated Fibroblasts; Captopril; Colorectal Neoplasms; Drug Synergism; Humans; Liver Neoplasms; Losartan; Lung Neoplasms; Neovascularization, Pathologic; Renin-Angiotensin System; Tumor Microenvironment | 2020 |
The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Colorectal Neoplasms; Disease Models, Animal; Gadolinium; Kupffer Cells; Liver Neoplasms; Macrophages; Male; Mice; Mice, Inbred CBA; Peptide Fragments; Renin-Angiotensin System | 2013 |
Blockade of the renin-angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Captopril; Cell Proliferation; Colorectal Neoplasms; Immunoenzyme Techniques; Liver Neoplasms; Liver Regeneration; Male; Mice; Mice, Inbred CBA; Neovascularization, Pathologic; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Burden; Tumor Cells, Cultured | 2014 |
Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.
Topics: Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Captopril; Colorectal Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred CBA; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System | 2010 |
Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
Topics: Adenocarcinoma; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers, Tumor; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Irbesartan; Liver Neoplasms, Experimental; Mice; Mice, Inbred CBA; Molecular Targeted Therapy; Neoplasm Proteins; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Tetrazoles; Tumor Burden; Up-Regulation; Vascular Endothelial Growth Factor A | 2011 |
Management of patients with persistent chest pain and ST-segment elevation during 5-fluorouracil treatment: report about two cases.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antimetabolites, Antineoplastic; Atrial Fibrillation; Captopril; Chest Pain; Colorectal Neoplasms; Coronary Angiography; Digoxin; Disease Management; Echocardiography; Electrocardiography; Fluorouracil; Humans; Laryngeal Neoplasms; Middle Aged; Myocardial Infarction; Nitrates; Verapamil | 2003 |
Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Captopril; Colorectal Neoplasms; Disease Models, Animal; Irbesartan; Liver Neoplasms; Male; Mice; Mice, Inbred CBA; Microscopy, Electron, Scanning; Necrosis; Tetrazoles | 2007 |
Inhibition of vascular endothelial growth factor-a signaling induces hypertension: examining the effect of cediranib (recentin; AZD2171) treatment on blood pressure in rat and the use of concomitant antihypertensive therapy.
Topics: Angiogenesis Inhibitors; Animals; Antihypertensive Agents; Antineoplastic Agents; Blood Pressure; Captopril; Cell Line, Tumor; Colorectal Neoplasms; Humans; Hypertension; Mice; Nifedipine; Quinazolines; Rats; Signal Transduction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |